⌘K
Loading ticker…
Artiva Biotherapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 95. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 11.4%, relative volume 1.51×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 95, Market Stance is mixed at 47, A/D rating D
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ARTV is in a stage 2 uptrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 1.4% / 70.4%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
ARTV is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $954K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $954K |
| VXFVanguard Extended Market ETF | 0.00% | $383K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ARTV Jan avg: -29.46% median: -29.46% win: 0% σ: 28.48% n: 2 2024-07-22 → 2026-05-29 | ARTV Feb avg: 15.65% median: 15.65% win: 50% σ: 48.03% n: 2 2024-07-22 → 2026-05-29 | ARTV Mar avg: -8.53% median: -8.53% win: 50% σ: 27.13% n: 2 2024-07-22 → 2026-05-29 | ARTV Apr avg: 19.34% median: 19.34% win: 50% σ: 56.10% n: 2 2024-07-22 → 2026-05-29 | ARTV May avg: -20.90% median: -20.90% win: 0% σ: 2.34% n: 2 2024-07-22 → 2026-05-29 | ARTV Jun avg: -21.76% median: -21.76% win: 0% σ: 0.00% n: 1 2024-07-22 → 2026-05-29 (current) | ARTV Jul avg: 48.50% median: 48.50% win: 50% σ: 70.95% n: 2 2024-07-22 → 2026-05-29 | ARTV Aug avg: 1.40% median: 1.40% win: 50% σ: 5.09% n: 2 2024-07-22 → 2026-05-29 | ARTV Sep avg: 12.50% median: 12.50% win: 50% σ: 30.24% n: 2 2024-07-22 → 2026-05-29 | ARTV Oct avg: 5.46% median: 5.46% win: 50% σ: 56.33% n: 2 2024-07-22 → 2026-05-29 | ARTV Nov avg: 8.10% median: 8.10% win: 50% σ: 25.36% n: 2 2024-07-22 → 2026-05-29 | ARTV Dec avg: -3.52% median: -3.52% win: 50% σ: 24.91% n: 2 2024-07-22 → 2026-05-29 |